Adimab
Adimab is a company focused on developing human monoclonal and bispecific antibodies for oncology, immunomodulation, inflammation, neuroscience, and pain.
Key facts
| AngelList URL | https://angel.co/adimab |
|---|---|
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/adimab#section-overview |
| Facebook URL | https://www.facebook.com/Adimab-LLC-1407716346107268/ |
| Full Address | 7 Lucent Drive Lebanon, NH 03766 |
| LinkedIn URL | https://www.linkedin.com/company/adimab-llc/ |
| Pitchbook URL | https://pitchbook.com/profiles/company/51339-43 |
| Official Website | http://adimab.com |
| Wellfound ID | adimab |
| Wikidata ID | Q100955919 |